Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis (Q28256427)

https://scigraph.springernature.com/pub.10.1007/s11914-011-0086-8

volume

10

0 references

issue

1

0 references

page(s)

93-100

0 references

exact match

0 references

cites work

Wnt signaling in osteoblasts and bone diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Eight genes are highly associated with BMD variation in postmenopausal Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

A rate-limiting role for Dickkopf-1 in bone formation and the remediation of bone loss in mouse and primate models of postmenopausal osteoporosis by an experimental therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Update in new anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

High bone density due to a mutation in LDL-receptor-related protein 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

High bone mass in mice expressing a mutant LRP5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Lrp5 functions in bone to regulate bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Essential role of beta-catenin in postnatal bone acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Lrp6 hypomorphic mutation affects bone mass through bone resorption in mice and impairs interaction with Mesd

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

The two faces of serotonin in bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Relation of serum serotonin levels to bone density and structural parameters in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Regulation of bone mass by serotonin: molecular biology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-011-0086-8

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass

21 January 2018

1 reference

12 December 2020

Caught up in a Wnt storm: Wnt signaling in cancer

1 reference

12 December 2020

Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

1 reference

12 December 2020

Clinical and molecular findings in osteoporosis-pseudoglioma syndrome

1 reference

12 December 2020

Efficacy of serotonin inhibition in mouse models of bone loss

1 reference

12 December 2020

Osteoporosis: now and the future

1 reference

12 December 2020

LRP5, serotonin, and bone: complexity, contradictions, and conundrums

1 reference

12 December 2020

Wnt signaling as a therapeutic target for bone diseases

1 reference

12 December 2020

The role of Dkk1 in bone mass regulation: correlating serum Dkk1 expression with bone mineral density

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020